Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Clinical trial NCT04886804 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04886804
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2026-12-30
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.